FindTrial
Sign In

Vyvanse

DRUG6 trials

Sponsors

New York State Psychiatric Institute, Kimberley Lakes, Massachusetts General Hospital, Shire, Vanderbilt University

Conditions

Attention Deficit DisorderAttention Deficit Hyperactivity DisorderAttention Deficit/Hyperactivity DisorderAttention Deficit/Hyperactivity Disorder (ADHD)Attention Deficit/Hyperactivity Disorder(ADHD)HealthyTraumatic Brain Injury

Phase 1

A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy Volunteers
CompletedNCT00919867
ShireHealthy
Start: 2009-06-24End: 2009-07-30Updated: 2021-06-14

Phase 3

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits
TerminatedNCT01000064
Vanderbilt UniversityAttention Deficit Disorder, Traumatic Brain Injury
Start: 2009-10-31End: 2015-05-31Updated: 2017-05-19

Phase 4

Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse
CompletedNCT00573534
New York State Psychiatric InstituteAttention Deficit Hyperactivity Disorder
Start: 2008-03-31End: 2010-03-31Updated: 2017-02-20
The Effects of Vyvanse(TM) on Brain Hemodynamics and Reading
CompletedNCT00733356
Kimberley LakesAttention Deficit/Hyperactivity Disorder
Start: 2008-07-31End: 2009-09-30Updated: 2018-02-14
Effect of Vyvanse on Driving in Young Adults With ADHD
CompletedNCT00801229
Massachusetts General HospitalAttention Deficit/Hyperactivity Disorder(ADHD)
Start: 2008-12-31End: 2010-07-31Updated: 2014-03-10
Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
CompletedNCT02675400
Seattle Children's HospitalAttention Deficit/Hyperactivity Disorder (ADHD)
Start: 2015-12-31End: 2018-08-31Updated: 2018-09-12